Keyword

trilaciclib

Description: Trilaciclib is a cyclin-dependent kinase 4/6 inhibitor used to protect bone marrow from chemotherapy-induced myelosuppression in cancer treatment.
Wikidata ID: wiki/Q105592965
OpenAlex ID: keywords/trilaciclib
2021 · Robert Roskoski Jr. · Pharmacological Research · 229
2017 · Shenghui He, Patrick J. Roberts, et al. · Science Translational Medicine · 172
2021 · Sohita Dhillon · Drugs · 123
2024 · Jeffrey Crawford, Dana Herndon, et al. · Future Oncology · 122
2021 · Sara Tariq, So Yeon Kim, et al. · Lung · 97
2021 · E. Panagiotou, G. Gomatou, et al. · Clinical & Translational Oncology · 82
2022 · Bryan Oronsky, Nacer Abrouk, et al. · Journal of Cancer · 77
2021 · Ye Hu, Jiyue Gao, et al. · Cancer Management and Research · 71
2018 · S Parylo, A Vennepureddy, et al. · Journal of Oncology Pharmacy Practice · 42
2021 · Kerrington Powell, V Prasad · Translational Oncology · 33
2021 · Gary H. Lyman, Nicole M. Kuderer, et al. · Frontiers in Oncology · 28
2026 · Irenaeus C. C. Chan, Pu Zhang, et al. · Nature Genetics · 23
Works count: 220
Citation count: 2,564
Year
Topic
Type